Solid Biosciences (SLDB) Non-cash Items (2018 - 2026)
Solid Biosciences' (SLDB) quarterly Non-cash Items came in at $5.4 million in Q1 2026, up 305.59% year-on-year from $1.3 million in Q1 2025, and up 404.27% quarter-over-quarter from $1.1 million in Q4 2025.
Solid Biosciences (SLDB) Non-cash Items (2018 - 2026) Analysis & Trends
Solid Biosciences has disclosed Non-cash Items across 6 years of filings, most recently posting $5.4 million for Q1 2026.
- Non-cash Items for Q1 2026 came in at $5.4 million, up 305.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.4 million (up 305.59% YoY), and the FY2025 annual result was $1.1 million, up 458.03% from the prior year.
- Non-cash Items came in at $5.4 million for Q1 2026 at Solid Biosciences, up from $1.1 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $5.4 million in Q1 2026 to a low of $193000.0 in Q4 2024.
- The 4-year median for Non-cash Items is $1.1 million (2025), against an average of $1.6 million.
- Across the five-year window, Non-cash Items tumbled 77.64% in 2024 and surged 458.03% in 2025, its largest moves.
- Solid Biosciences' Non-cash Items stood at $863000.0 in 2023, then sank by 77.64% to $193000.0 in 2024, then soared by 458.03% to $1.1 million in 2025, then jumped by 404.27% to $5.4 million in 2026.
- The last three Non-cash Items figures came in at $5.4 million (Q1 2026), $1.1 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Solid Biosciences | 789.54 Mn | 408.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.43 Mn |
| Mar 31, 2026 | 5.43 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | 193,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 998,150.00 |
| Jun 30, 2024 | 998,150.00 |
| Dec 31, 2023 | 863,000.00 |
| Dec 31, 2023 | 863,000.00 |
| Dec 31, 2020 | 910,000.00 |
| Dec 31, 2020 | 910,000.00 |